[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 181″]
Nicox has had quite a year, bringing two new ophthalmology projects to the market through partnerships with Bausch + Lomb and Eyevance Pharmaceuticals. So what’s next for the global company? CEO Michele Garufi provides answers. James V. Mazzo, global president for Carl Zeiss Meditec’s Strategic Business Unit Ophthalmic Devices, sits down with us at OIS@ASCRS to talk about his three years at the company and what the future might bring.